Zena Jameel, MD

Cancer Focus:
Breast Cancer, Ductal Carcinoma In Situ, Inflammatory Breast Cancer, Invasive Ductal Carcinoma, Triple Negative Breast Cancer

Dr. Jameel earned her MBCHB at the University of Baghdad College of Medicine, Baghdad, Iraq. She completed her Pathology Residency in the Department of Pathology and Laboratory Medicine at Rutgers New Jersey Medical School, where she also served as Chief Resident. Dr. Jameel completed a Breast Pathology Fellowship in the Department of Pathology at Memorial Sloan Kettering Cancer Center. Dr. Jameel recently completed an Advanced Pathology Fellowship as a Surgical Pathology Assistant in the Department of Pathology at Johns Hopkins Hospital.

Dr. Jameel’s clinical and research interests focus on breast pathology.

Education & Training

Fellowship:

• Memorial Sloan Kettering Cancer Center - Breast Pathology

Residency:

• Rutgers New Jersey Medical School - Pathology

Medical School:

• University of Baghdad College of Medicine - MD

• Jameel Z, Rosa M. Interobserver Variability in the Measurement of the Metastatic Tumor Size on Breast Sentinel Lymph Nodes. Arch Pathol Lab Med. 2025 Oct. Pubmedid: 41051109.
• Han HS, Aldrich AL, Garg SK, Weinfurtner RJ, Nguyen JV, Mo Q, Whiting J, Childress J, Soliman H, Costa R, Armaghani A, Soyano A, Kiluk J, Hoover S, Lee MC, Khakpour N, Shenoi N, Jameel Z, Koski GK, Czerniecki BJ. Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer: A Nonrandomized Clinical Trial. JAMA Oncol. 2025 Feb.11(2):119-127. Pubmedid: 39636623. Pmcid: PMC11622104.
• Waqas A, Khan A, Ozturk ZG, Saeed-Vafa D, Chen W, Dhillon J, Bychkov A, Bui MM, Ullah E, Khalil F, Chumbalkar V, Jameel Z, Bittar HT, Singh RS, Parwani AV, Schabath MB, Rasool G. REASONING BEYOND ACCURACY: EXPERT EVALUATION OF LARGE LANGUAGE MODELS IN DIAGNOSTIC PATHOLOGY. medRxiv. 2025 Apr. Pubmedid: 40297448. Pmcid: PMC12036407.
• Mooney S, Dutmers J, Jameel Z, Weinfurtner RJ. Calcified axillary lymph nodes in a case of de novo metastatic breast cancer. Radiol Case Rep. 2024 Jan.19(1):483-488. Pubmedid: 38046920. Pmcid: PMC10692459.
• Bari S, Li J, Kang D, Jameel Z, Czerniecki BJ, Costa RLB. A Real-World Data Retrospective Cohort Study of HER2-positive, Early-Stage Breast Cancer in Patients 70 Years of Age or Older: Natural History, Treatment Patterns, and Outcomes. Clin Breast Cancer. 2023 Jun.23(4):378-387. Pubmedid: 36805387.
• Jameel Z, Kiluk J, Rosa M. Malignant Adenomyoepithelioma of the Breast and Associated Epithelial-Myoepithelial Carcinoma; A Rare Case Report. Int J Surg Pathol. 2022 Aug.30(5):569-573. Pubmedid: 35138180.
• Bari S, Boulware D, Li J, Loftus L, Soyano Muller A, Jameel Z, Khong H, Czerniecki BJ, Costa RLB. A Real-World Data Retrospective Cohort Study of Low Estrogen Receptor-Positive Early Breast Cancer: Natural History and Treatment Outcomes. Breast Cancer (Dove Med Press). 2022 Aug.14:199-210. Pubmedid: 35967746. Pmcid: PMC9365325.
• Siegel E, Rosa M, Khakpour N, Qin D, Jameel Z. Erroneous diagnosis of primary fibrosarcoma of the breast: The value of the multidisciplinary breast team approach. Breast J. 2021 May.27(5):472-474. Pubmedid: 33619764.
• Parikh P, Jameel Z, Falcon S, Rosa M, Kiluk J, Hoover S, Soliman H, Ataya D. Adenomyoepithelioma of the breast: Case series and literature review. Clin Imaging. 2021 Jul.75:157-164. Pubmedid: 33607537.
• Gangadharan A, Nyirenda T, Patel K, Jaimes-Delgadillo N, Coletta D, Tanaka T, Walland AC, Jameel Z, Vedantam S, Tang S, Mannion C, Lee GY, Goy A, Pecora A, Suh KS. Prolactin Induced Protein (PIP) is a potential biomarker for early stage and malignant breast cancer. Breast. 2018 Jun.39:101-109. Pubmedid: 29656222.
• Dozier J, Jameel Z, McCain DA, Hassoun P, Bamboat ZM. Massive malignant solitary fibrous tumor arising from the bladder serosa: a case report. J Med Case Rep. 2015 Mar.9:46. Pubmedid: 25884588. Pmcid: PMC4358716.